Original contributionp53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens☆
References (21)
- et al.
Increased expression of the mutant forms of p53 oncogene in primary lung cancer
Lancet
(1990) Neoplastic asbestos-induced diseases
- et al.
Mesothelioma
- et al.
p53 Mutations in colorectal cancer
- et al.
Mutation of the p53 gene in human soft tissue sarcomas: Association with abnormalities of the RB1 gene
Oncogene
(1990) - et al.
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
Oncogene
(1991) - et al.
Genetic alterations of the p53 gene are a feature of malignant mesotheliomas
Cancer Res
(1991) - et al.
The p53 tumor suppressor gene
Nature
(1991) - et al.
Mutations in p53 as potential molecular markers for human breast cancer
- et al.
p53 Expression is common in malignant mesothelioma
Histopathology
(1992)
There are more references available in the full text version of this article.
Cited by (82)
Malignant and Borderline Mesothelial Tumors of the Pleura
2018, Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition SeriesPseudoneoplastic Lesions of the Lungs and Pleural Surfaces
2018, Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition SeriesDiagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions
2011, Journal of the Egyptian National Cancer InstituteCitation Excerpt :The higher positivity rate in the present study, compared to these studies, may be attributed to the difference in the antibodies used where clone DO-1 MoAb had been used in the current study. VPp958 MoAb was used by Hasteh et al. [20], clone BP53-12 MoAb was used by Cagle et al. [21] and Do-7 MoAb was used by Mayall et al. [16]. Also in Hasteh et al. study [20], all malignant cases had mesothelioma and in Cagle et al. [21], 69% of their studied malignant cases had mesothelioma, while in the present study only two cases had malignant mesothelioma.
Malignant and Borderline Mesothelial Tumors of the Pleura
2011, Practical Pulmonary Pathology E-Book: A Diagnostic Approach, Second EditionPseudoneoplastic Lesions of the Lungs and Pleural Surfaces
2011, Practical Pulmonary Pathology E-Book: A Diagnostic Approach, Second EditionMalignant and Borderline Mesothelial Tumors of the Pleura
2011, Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series
- ☆
Presented in part at the 82nd Meeting of the United States and Canadian Academy of Pathology, New Orleans, LA, March 15, 1993.
Copyright © 1994 Published by Elsevier Inc.